Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 27Recruiting 15Active not recruiting 8Unknown 6Terminated 6Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Hemorrhage 1Anastomotic Leak 1

Interventions

Carboplatin 127Cisplatin 125Drug Therapy 116Bevacizumab 102Capecitabine 100Oxaliplatin 99Radiotherapy 97Gemcitabine 87tislelizumab 86Paclitaxel 86Cyclophosphamide 85pembrolizumab 77Specimen Handling 77toripalimab 70Magnetic Resonance Spectroscopy 63Injections 63Fluorouracil 63sintilimab 58Surgical Procedures, Operative 58anlotinib 53Docetaxel 52130-nm albumin-bound paclitaxel 51fludarabine 47Standard of Care 45Pemetrexed 45Immune Checkpoint Inhibitors 45Blood Specimen Collection 43venetoclax 42Leucovorin 42lenvatinib 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Congresses as Topic × Clear all
NCT06129851 2023-11-13

Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer

University of Kansas Medical Center

Phase 2 Not yet recruiting
90 enrolled
Genitourinary

Prostatic Neoplasms

NCT06049758 2023-09-22

D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy

General Committee of Teaching Hospitals and Institutes, Egypt

Phase NA Not yet recruiting
80 enrolled

Hemorrhage, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡